Can-Fite BioPharma Ltd. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2023 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Can-Fite BioPharma Ltd. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2023 to Q4 2024.
Can-Fite BioPharma Ltd. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending December 31, 2024 was $29K, a 1350% increase year-over-year.

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$29K	+$27K	+1350%	Dec 31, 2024	20-F	2025-04-14
Q4 2023	$2K			Dec 31, 2023	20-F	2024-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.